Free Trial

435 Shares in McKesson Co. (NYSE:MCK) Purchased by Milestone Asset Management LLC

McKesson logo with Medical background

Milestone Asset Management LLC purchased a new position in McKesson Co. (NYSE:MCK - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 435 shares of the company's stock, valued at approximately $293,000.

A number of other institutional investors have also recently made changes to their positions in the stock. LVW Advisors LLC increased its holdings in shares of McKesson by 3.5% in the 1st quarter. LVW Advisors LLC now owns 528 shares of the company's stock worth $355,000 after buying an additional 18 shares during the last quarter. Sweeney & Michel LLC bought a new position in shares of McKesson during the 1st quarter valued at $548,000. NBC Securities Inc. grew its holdings in shares of McKesson by 106,150.0% during the 1st quarter. NBC Securities Inc. now owns 2,125 shares of the company's stock valued at $1,430,000 after purchasing an additional 2,123 shares during the last quarter. Parkside Advisors LLC bought a new position in shares of McKesson during the 1st quarter valued at $214,000. Finally, Czech National Bank grew its holdings in shares of McKesson by 4.6% during the 1st quarter. Czech National Bank now owns 28,785 shares of the company's stock valued at $19,372,000 after purchasing an additional 1,261 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of McKesson stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $726.51, for a total transaction of $394,494.93. Following the transaction, the chief accounting officer now owns 1,972 shares of the company's stock, valued at $1,432,677.72. The trade was a 21.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Britt J. Vitalone sold 6,336 shares of the business's stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total transaction of $4,544,812.80. Following the completion of the transaction, the chief financial officer now directly owns 14,760 shares in the company, valued at $10,587,348. This trade represents a 30.03% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,747 shares of company stock worth $9,852,587. 0.11% of the stock is owned by company insiders.

McKesson Stock Performance

Shares of MCK traded down $4.94 during mid-day trading on Wednesday, hitting $709.94. 644,590 shares of the company traded hands, compared to its average volume of 914,044. The stock has a 50-day moving average price of $697.33 and a two-hundred day moving average price of $639.30. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $731.00. The stock has a market cap of $88.82 billion, a price-to-earnings ratio of 32.51, a P/E/G ratio of 1.29 and a beta of 0.53.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The company had revenue of $90.82 billion for the quarter, compared to the consensus estimate of $94 billion. During the same quarter in the prior year, the company earned $6.18 earnings per share. McKesson's revenue was up 18.9% on a year-over-year basis. On average, analysts forecast that McKesson Co. will post 32.77 EPS for the current year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be given a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 annualized dividend and a yield of 0.40%. McKesson's dividend payout ratio (DPR) is 10.99%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on MCK shares. Wells Fargo & Company raised their price target on shares of McKesson from $691.00 to $766.00 and gave the stock an "equal weight" rating in a report on Tuesday. Wall Street Zen raised shares of McKesson from a "buy" rating to a "strong-buy" rating in a report on Friday, May 30th. Mizuho raised their price target on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. Evercore ISI raised their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Finally, Bank of America raised their target price on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $692.46.

Get Our Latest Stock Analysis on MCK

McKesson Company Profile

(Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Featured Stories

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Should You Invest $1,000 in McKesson Right Now?

Before you consider McKesson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.

While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines